Authors: Bereznyakov I. G., Levadna Y. V., Doroshenko, O. V., Sidorov D. Y , Pozhar V. I.
The article deals with the socio-economic status (SES) and the prevalence of risk factors (RF) in patients with diabetes mellitus (DM) type 2 and essential hypertension (EH). Determined the prevalence of risk factors, depending on the occupational status, smoking, alcohol consumption, low physical activity influence on mortality according to age. Paying special role metabolic syndrome, its dependence on SES. Attention is given to the link between SES, presence of DM type 2, the presence of hypertension and the prevalence of risk factors for cardiovascular disease. Comorbid diseases becomes actualer when combined diseases have great medical and social importance. These diseases include such common diseases accompanied by high morbidity, disability and mortality, treatment and which prevention causes high economic costs. Diabetes mellitus (DM) type 2 and hypertension can be included for these deasease confidently. Distribution and danger of these diseases give necessity to study the pathogenesis, treatment and prevention.
Diabetes, especially type 2, is a very common disease, and epidemiological studies in recent years suggest the "epidemic of diabetes." primary goal of treatment of patients with hypertension is "to achieve maximum reduction in the long-term total risk of cardiovascular morbidity and mortality. It requires the treatment of all modified risk factors, including smoking, dyslipidemia, abdominal obesity or diabetes, adequate therapy associated with hypertension clinical conditions and reduce high blood pressure. Personal risk factors for cardiovascular disease (smoking, alcohol abuse, sedentary lifestyle, poor diet, obesity) are more common in individuals with low SES. Obesity and smoking are often seen as indicators of social stress. Most studies have reported on the relationship between the parameters of SES and cardiovascular disease. An inverse relationship between SES and metabolic syndrome is established, which is largely mediated by lifestyle.
Кеу words: diabetes mellitus, essential hypertension, socio-economic status, risk factors.
2. Engberg S, Vistisen D, LauC. [et al.]Progression to impaired glucose regulation and diabetes in the population-based Inter 99 study. Diabetes Care. 2009;32( 4): 606–611.
3. Cowie C.C., Rust K.F., Ford E.S.[et al.] Full accounting of diabetes and pre-diabetes in the U.S. population in 1988-1994 and 2005-2006.Diabetes Care. 2009;32:287–294.
4. American Diabetes Association. Economic costs of diabetes in the U.S. in 2007. Diabetes Care.2008;31:596–615.
5. Ripsin C.M. Management of blood glucose in type 2 diabetes mellitus. Am. Fam. Physician. 2009;79(1): 29–36.
6. Centers for Disease Control and Prevention. National Diabetes Fact Sheet: General Information and National Estimates on Diabetes in the United States, 2007. Atlanta, GA, U.S. Department of Health and Human Services, Centers for Disease Control and Prevention, 2008.
7.Johannesson A., Larsson G.-U., RamstrandN. [et al.]Incidence of lower-limb amputation in the diabetic and nondiabetic general population. A 10-year population-based cohort study of initial unilateral and contralateral amputations and reamputations. Diabetes Care. 2009; 32(2):275–280.
8. MankovskyiB.N. [2013 indiabetology: keyevents, relevantresearchandnewclinicalguidelines]. Health Ukraine.- 2014; 06 (331):24-26.
9. Chobanian A. V., Bakris G. L., Black H. R. [et al.] for the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure, National Heart, Lung, and Blood Institute, National High Blood Pressure Education Program Coordinating Committee Seventh report of the Joint National Committee on Prevention, Detection, Evaluation and Treatment of High Blood Pressure. Hypertension. 2003;42:1206–1252.
10. CovalenkoVN, TalaevaTV, Bratus VV. [The significance of hypertension as a factor for cardiovascular disease, the mechanisms of its pro-atherogenic actions]. Ukrain. cardіol. J. 2010;1:28-41.
11. Sirenko YuM.Arterialna gipertenziya [Hypertension]. Кiev: Morion, 2001. 176 p.
12. ErmacovichII, SiroshtanGM, GerasimenkoZhD, Pashchenko LS.[CardiaccareintheKharkivregionandopportunitiestoimprove].Ukrain. Cardіol. J. 2009; 6: 56–61.
13. KovalenkoVM, Kornatsky VM. [ImplementationofgovernmentprogramsagainsthypertensioninUkraine].Ukrain. cardіol. J. 2010;6:7–12.
14. KornatskyVMRevenkoLI. [MedicalandsocialaspectsofcerebrovasculardiseaseinUkraine].Ukrain. cardіol. J. 2011;1:86–92.
15. Lloyd-JonesD, AdamsR, CarnethonM[et al.] for the American Heart Association Statistics Committee and Stroke Statistics Subcommittee. Heart Disease and Stroke Statistics-2009 Update. A Report From the American Heart Association Statistics Committee and Stroke Statistics Subcommittee. Circulation.2009;119:e21–e181.
16. Vilensky BS. Stroke - state of the art . Nevrologich J. 2008;2:4–10.
17. Kovalenko VN, Kornatsky VM, Manoylenko T. et al. Demografіya i zdorovya populacii Ukraini. [Demographics and health of the people of Ukraine]. Kyiv: 2010. 142p.
18. Mishchenko TS. [Analysis of the epidemiology of cerebrovascular disease in Ukraine] Vascular diseases of the brain. 2010; 3:2-9.
19. Khobzey NK, Mishchenko TS, Golik VA Ipatov AVю Epidemiology of stroke, clinical aspects and expertise in Ukraine.Vascular diseases of the brain. 2010; 4: 2-5.
20. Dolzenko MN How to prevent organ damage in hypertension? Correction of metabolic disorders. Health of Ukraine. 2014; 06 (331):18-19
21. A guideline on hypertension of the European Society of Hypertension (ESH) and the European Society of Cardiology (ESC) 2013.Hypertension. 2013;4:61-130
22. Ose D, Wensing, Szecsenyi MJ. [et al.] Impact of primary care-based disease management on the health-related quality of life in patients with type 2 diabetes and comorbidity. Diabetes Care. 2009;32(9): 1594–1596.
23. Mancia G, de Backer G, Dominiczak A.[et al.]. 2007 Guidelines for the Management of Arterial Hypertension. The Task Force for the Management of Arterial Hypertension of the European Society of Hypertension (ESH) and of the European Society of Cardiology (ESC) J. Hypertens. 2007; 25:1105–1187.
24. Izzo R, Simone GDe, ChinaliM. [et al.]. Insufficient control of blood pressure and incident diabetes. Diabetes Care. 2009; 32(50):845–850.
25. Monami M, Vivarelli M, DesideriCM [et al.]. Pulse pressure and prediction of incident foot ulcers in type 2 diabetes. Diabetes Care. 2009; 32 (5):897–899.
26. Obrezan AG, Bicadze RM. Structure of cardiovascular disease in patients with Type 2 diabetes, diabetic cardiomyopathy as a special state of the myocardium. Intern. EndocrinologyJ. 2010; 4:18-22.
27. Adler AI, Stratton IM, Neil HA[et al.]. Association of systolic blood pressure with macrovascular and microvascular complications of type 2 diabetes (UKPDS 36): Prospective observational study. BMJ. 2000; 321:412–419.
28. Karlamanglaa AS , Singerb BH, William DR [et al.]. Impact of socioeconomic status on longitudinal accumulation of cardiovascular risk in young adults: the CARDIA Study (USA). Soc. Sci. Med. 2005;60: 999–1015.
29. Mieczkowska J. Mosiewicz J. Socioeconomic status and cardiovascular disease risk. Heart. 2008; 94(8):1075.
30. Rosero-Bixby L. Dow WH. Surprising gradients in mortality, health, and biomarkers in a Latin American population of adults. J. Gerontol. Series B. 2009; 63 (1): 105–117.
31. Lantz PM, Golberstein E, House JS, Morenoff J. Socioeconomic and behavioral risk factors for mortality in a national 19-year prospective study of U.S. adults. Soc. Sci. Med. 2010; 70:1558–1566.
32. Khang YH, Lynch JW, Yang S. [et al.]. The contribution of material, psychosocial, and behavioral factors in explaining educational and occupational mortality inequalities in a nationally representative sample of South Koreans: relative and absolute perspectives. Soc. Sci. Med. 2009; 68(5): 858–866.
33. Meara ER Richards S, Cutler DM. The gap gets bigger: changes in mortality and life expectancy, by education, 1981-2000. Health Affairs. 2008; 27(2}:350–360.
34. Dray-Spira R, Gary-Webb TL, Brancati FL. Educational disparities in mortality among adults with diabetes in the U.S. Diabetes Care. 2010;33(6).1200–1205.
35. Feinglass J, Lin S, Thompson J. [et al.]. Baseline health, socioeconomic status and 10-year mortality among older middle-aged Americans: findings from the health and retirement study, 1992–2002. J. Gerontol. 2007; 62B(4): S209–S217.
36. Kokkinos P, Myers J, Nylen E.[et al.] Exercise capacity and all-cause mortality in African American and Caucasian men with type 2 diabetes. Diabetes Care. 2009;32(4):623–628.
37. Sui X, LaMonte MJ, Laditka JN [et al.]. Cardiorespiratory fitness and adiposity as mortality predictors in older adults. J. Am. Med. Ass. 2007; 298 (21): 2507–2516.
38. Preiss D, Zetterstrand S,. McMurrayJJV [et al.]. Predictors of development of diabetes in patients with chronic heart failure in the Candesartan in Heart Failure Assessment of Reduction in Mortality and Morbidity (CHARM) program. Diabetes Care. 2009;32(5):915–920.
39. Orpana HM, Berthelot JM, Kaplan MS [et al.] BMI and mortality: results from a national longitudinal study of Canadian adults. Obesity. 2010;18(1 ): 214-218.
40. Reis JP, Araneta MR, Wingard DL [et al.]. Overall obesity and abdominal adiposity as predictors of mortality in U.S. white and black adults. Annals Epidemiol. 2009;19: 134–142.
41. Mitchenko AI, Logvynenko AA, Romanov V. [Optimization of treatment of dyslipidemia and disorders of carbohydrate metabolism in patients with hypertension with metabolic syndrome and thyroid dysfunction]. Ukr. cardiology. J. 2010;1:73–80.
42. Nieto F.J. Understanding the pathophysiology of poverty. Int. J. Epidemiol. 2009; 38: 787–790.
43. Kivimaki M, Lawlor DA, Davey Smith G [et al.]. Socioeconomic position, co-occurrence of behavior-related risk factors, and coronary heart disease: the Finnish Public Sector study. Am. J. Public Health. 2007; 97: 874–879.
44. Roberts BA, Der G, Deary IJ, Batty GD. Reaction time and established risk factors for total and cardiovascular disease mortality: comparison of effect estimates in the follow-up of a large, UK-wide, general-population based survey. Intelligence. 2009;37:561–566.
45. Vasilieva NYu, Zharinov OI, Kuts VA, Epanchintseva OA.[ Diagnosis of cognitive impairment in patients with hypertension]. Ukr. kardіol. J. 2009;5:91-100.
46. Gale CR, Deary IJ, Batty GD. Intelligence and carotid atherosclerosis in older people: Cross-sectional study. J. Am. Geriatr. Soc. 2008;56:769−771.
47. Steptoe A, Shamaei-Tousi A, Gylfe A. [et al.]. Socioeconomic status, pathogen burden and cardiovascular disease risk. Heart. 2007;93(12):1567–1570.
48. Mankovsky BN.[Type 2 diabetes and metabolic syndrome: what you need to know about satellites practitioner diabetes].Health Ukraine. 2014;10:29.
49. Hrebtіy GI. [Structural and geometric remodeling of the left ventricle of the heart, hemodynamic and vascular endothelial function in patients with hypertension depending on body weight]. Ukr. cardiology. J. 2009;4: 49-52.
50. TodurovBM, KundinVY, NobisOE.[Modernpossibilitiesofmyocardialscintigraphyinthediagnosisoflesionsoftheleftventriclemyocardiumoftheheart].Ukr. kardіol. J. 2010;5: - P. 100-108.
51. KimBJ, KimBS, SungKC [etal.]. Association of smoking status, weight change, and incident metabolic syndrome in men: a 3-year follow-up study. Diabetes Care. 2009;32(7): 1314–1316.
52. Wada T, Urashima M, Fukumoto T. Risk of metabolic syndrome persists twenty years after the cessation of smoking. Intern Med. 2007; 46:1079–1082.
53. Sánchez-Chaparro MA, Calvo-Bonacho E, González-Quintela A [et al.] on behalf of the Ibermutuamur CArdiovascular RIsk Assessment (ICARIA) study group.Occupation-related differences in the prevalence of metabolic syndrome. Diabetes Care. 2008;31(9): 1884–1885.
54. Chen Y, Sigal RJ, Lin M. Impacts of diabetes and hypertension on the risk of hospitalization among less educated people. J. Human Hypertens. 2007;21: 225–230.
55. Gregg EW, Gu Q, Cheng YJ [et al.]. Mortality trends in men and women with diabetes, 1971-2000. Ann. Intern Med. – 2007;147:149–155.
56. Ferrara A, Mangione CM, Kim C. [et al.] for the Translating Research Into Action for Diabetes (TRIAD) study group Sex disparities in control and treatment of modifiable cardiovascular disease risk factors among patients with diabetes. Translating Research Into Action for Diabetes (TRIAD) study. Diabetes Care. 2008;31(1): 69–74.
57. The TRIAD study group. Health systems, patients factors, and quality of care for diabetes. A synthesis of findings from the TRIAD Study. Diabetes Care. 2010;33(4): 940–947.
58. Heraclides A., Chandola T, Witte DR, Brunner EJ. Psychosocial stress at work doubles the risk of type 2 diabetes in middle-aged Women. Evidence from the Whitehall II study. Diabetes Care. 2009;32(12): 2230–2235.
59. Carlsson AC, Wändell PE, U. de Faire, Hellénius ML. Risk factors associated with newly diagnosed high blood pressure in men and women. Am. J. Hypertens. 2008;21(7): 771–777.
60. Davydova IV. [Features of the course and tactics of hypertensive patients aged 60 years and older according to current guidelines]. Health Ukraine. 2014;06 (331):22-23
61. Marotta T, Viola S, Ferrara F, Ferrara LA. Improvement of cardiovascular risk profile in an elderly population of low social level: the ICON (Improving Cardiovascular risk profile in Older Neapolitans) study. J. Human Hypertens. 2007; 21: 76–85.
62. Halldin M, Rosell M, de Faire U, Hellenius ML. The metabolic syndrome: prevalence and association to leisure-time and work-related physical activity in 60-year-old men and women.Nutr. Metab. Cardiovasc. Dis. – 2007. – Vol. 17. – Р. 349–357.
63. Gu D, Wildman RP, Wu X [et al.]. Incidence and predictors of hypertension over 8 years among Chinese men and women. J. Hypertens. 2007; 25: 517–523.
64. Haslam D. W. Obesity. Lancet. 2005; 366:1197–1209.
65. Radchenko AD, Martsovenko IM, Syrenko N. [Do doctors in Ukraine risk stratification of patients with hypertension?] Radchenko AD. Ukr. kardіol. J. 2009;5:7-16.
66. Sirenko Y.M. [The program of prevention and treatment of hypertension in Ukraine]. Hypertension. 2008;2:S.83-88.
67. Kupchynskaya OG. The evolution of left ventricular hypertrophy in hypertensive patients provided occasional intake of antihypertensive drugs. Ukr. Cardiology. J. 2011; 3: 50-54.
68. Piette JD, Kerr EA. The impact of comorbid chronic conditions on diabetes care. Diabetes Care. 2006; 29(3):725–731.
69. Hofer TP, Zemencuk JK, Hayward RA. When there is too much to do: how practicing physicians prioritize among recommended interventions. J. Gen. Intern. Med.2004;19:646–653.
70. Egan BM, Lackland DT, Cutler NE. Awareness, knowledge, and attitudes of older americans about high blood pressure: implications for health care policy, education, and research. Arch Intern. Med. 2003;163:681–687.
71. Moser M. No surprises in blood pressure awareness study findings: we can do a better job. Arch Intern. Med. 2003;163:654–656.
72. Kovalenko VM. [Prevention and treatment of myocardial infarction in Ukraine]. Ukr. cardiology. J. 2009; 4: 7-12.